Hatch-Waxman Act Updates in 2014

Yogesh Bahl is a Managing Director in AlixPartners’ Financial Advisory Services practice and leads its life sciences efforts. He has more than 20 years of experience as a financial consultant specializing in litigation consulting, forensic reviews, and enterprise improvement. Yogesh has served as a financial expert in litigation involving life sciences companies and issues related to intellectual property, breach of contract, and damages, among others.  In addition, Yogesh has experience in managing risk-related operational issues across the research and development and commercial value chains; he has extensive experience with strategic alliances, corporate integrity agreements, auditing and monitoring, and third-party risk management. He has helped companies improve operations in connection with managing the application of accounting principles, gross-to-net revenue reporting, product diversion, and counterfeiting issues.

Yogesh holds an MBA in finance and statistics and a Bachelor of Science in accounting and international business from New York University’s Stern School of Business. He is a certified public accountant (AlixPartners is not a certified public accounting firm) and a member of the American Institute of Certified Public Accountants and the New York State Society of CPAs. He has authored articles on fraud and supply chain management and is a frequent and sought-after speaker. Yogesh serves on the board of New York Asian Women’s Center, an organization that helps women and their children overcome domestic violence and other forms of abuse by empowering them to govern their own lives.

Brendan is a dedicated antitrust and securities fraud litigator, who possesses a wealth of litigation and trial experience as a Deputy Public Defender, associate at Boies, Schiller & Flexner for five years, and now partner at Lieff Cabraser. A member of the Executive Committee of the Antitrust Section of The Bar Association of San Francisco, Brendan is also a frequent speaker on antitrust law and complex class actions. Glackin also teaches trial advocacy through NITA.

Ha Kung Wong is a partner at Fitzpatrick, Cella, Harper & Scinto and practices general intellectual property law with an emphasis on complex patent and trade secret litigation in pharmaceuticals, biologics and chemistry. Cases Mr. Wong has litigated include those related to proton pump inhibitors, anti-epileptic drugs, anti-tussives, ADHD drugs and other pharmaceuticals. Mr. Wong also has extensive experience with intellectual property counseling, pre-suit investigations, licensing and due diligence.

Mr. Wong currently is the Chair of the Recruiting Committee for Fitzpatrick, serves as faculty for NITA (the National Institute of Trial Advocacy) and Lawline, and has been named a "Furthered 40" by Lawline for his contributions.  He was also listed as a Rising Star in Intellectual Property Litigation in the 2012 and 2013 issues of Super Lawyers: New York Metro Edition.  He received his Bachelor’s degree in Chemistry, with Distinction, and Biochemistry from the University of Illinois Urbana-Champaign and his Juris Doctor, cum laude, from the University of Notre Dame.

William Coppola has over 20 years of experience representing numerous clients, including universities, regarding a wide spectrum of patent and intellectual property matters.  Mr. Coppola presently is a Senior Patent Counsel at Sanofi in Bridgewater, NJ.  His responsibilities at Sanofi have included securing and defending world-wide patent protection, performance of due diligence with respect to new technologies, licensing and negotiation of agreements, performance of competitive and freedom-to-operate analyses, and patent litigation in the US and globally.  Mr. Coppola’s litigation responsibilities have included management of numerous Hatch-Waxman litigations, ITC litigation, and PMNOC litigation in Canada.

Mr. Coppola received his J.D. from Seton Hall University Law School in 1991, where he was a member of the Seton Hall Constitutional Law Journal.  He received his graduate degree in Biochemistry from the University of South Florida in Tampa, Florida, and his undergraduate degree in Chemistry from the University of Delaware.  He is a member of the Phi Kappa Phi Honor society, a registered patent attorney, and is admitted to practice law in New Jersey and Florida.

William Coppola has over 20 years of experience representing numerous clients, including universities, regarding a wide spectrum of patent and intellectual property matters.  Mr. Coppola presently is a Senior Patent Counsel at Sanofi in Bridgewater, NJ.  His responsibilities at Sanofi have included securing and defending world-wide patent protection, performance of due diligence with respect to new technologies, licensing and negotiation of agreements, performance of competitive and freedom-to-operate analyses, and patent litigation in the US and globally.  Mr. Coppola’s litigation responsibilities have included management of numerous Hatch-Waxman litigations, ITC litigation, and PMNOC litigation in Canada.

Mr. Coppola received his J.D. from Seton Hall University Law School in 1991, where he was a member of the Seton Hall Constitutional Law Journal.  He received his graduate degree in Biochemistry from the University of South Florida in Tampa, Florida, and his undergraduate degree in Chemistry from the University of Delaware.  He is a member of the Phi Kappa Phi Honor society, a registered patent attorney, and is admitted to practice law in New Jersey and Florida.